Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-28T16:54:04.786Z Has data issue: false hasContentIssue false
  • English
  • Français

Review of College guidelines on high-dose neuroleptic use in a psychiatric intensive care unit

Published online by Cambridge University Press:  02 January 2018

Hugh Jones ,
Rachel Jones  and
James V. Lucey
Hugh Jones*
Affiliation:
Department of Psychiatry, Homerton Hospital, Homerton Row, London E9 6SR
James V. Lucey
Affiliation:
Department of Psychological Medicine, St Bartholomew's and the Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, University of London
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Original Papers
Information
Psychiatric Bulletin , Volume 22 , Issue 10 , October 1998 , pp. 598 - 600
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1998 The Royal College of Psychiatrists

References

Hillam, J. & Evans, C. (1996) Neuroleptic drug use in psychiatric intensive therapy units: problems with complying with the consensus statement. Psychiatric Bulletin, 20, 82–84.Google Scholar
Overall, J. E. & Gorham, D. R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 10. 799–812.Google Scholar
Peralta, V., Cuesta, M. J., Caro, F., et al (1994) Neuroleptic dose and schizophrenic symptoms. Acta Psychiatrica Scandinavica, 90, 354–357.Google Scholar
Rey, M.-J., Schulz, P., Costa, C., et al (1989) Guidelines for the dosage of neuroleptics. International Clinical Psychopharmacology, 4, 95–110.Google Scholar
Rifkin, A., Doddi, S., Karagi, B., et al (1991) Dosage of haloperidol for schizophrenia. Archives of General Psychiatry, 46, 166–170.Google Scholar
Rifkin, A., Doddi, S., Karagi, B., et al (1994) Dosage of haloperidol for mania. British Journal of Psychiatry, 166, 113–116.Google Scholar
Schulz, P., Rey, M., Dick, P., et al (1989) Guidelines for the dosage of neuroleptics, 2: changing from daily oral to long acting injectable neuroleptics. International Clinical Psychopharmacology, 4, 105–114.Google Scholar
Thompson, C. (1994) The use of high dose antipsychotic medication. College consensus statement. British Journal of Psychiatry, 164, 448–458.Google Scholar
Van Putten, T., Marder, S. R. & Mintz, J. (1990) A controlled dose comparison of haloperidol for newly admitted schizophrenic patients. Archives of General Psychiatry, 47, 754–758.Google Scholar
Walker, Z. & Seifert, R. (1994) Violent incidents in a psychiatric intensive care unit. British Journal of Psychiatry, 164, 826–828.Google Scholar
World Health Organization (1992) The ICD–10 Classification of Mental and Behavioural Disorders. Geneva: WHO.Google Scholar
Yudofsky, S. C., Silver, J. M., Jackson, W., et al (1986) The Overt Aggression Scale for the objective rating of verbal and physical aggression. American Journal of Psychiatry, 143, 35–39.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.